Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View


EyePoint Pharmaceuticals Reports Q1 2021 Net Product Revenue For YUTIQ Was $3M; Net Product Revenue For DEXYCU Was $3.8M


Benzinga | May 5, 2021 07:22AM EDT

EyePoint Pharmaceuticals Reports Q1 2021 Net Product Revenue For YUTIQ Was $3M; Net Product Revenue For DEXYCU Was $3.8M






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC